- Viollet B, Andreelli F, Jorgensen SB, Perrin C,
Geloen A, Flamez D, Mu J, Lenzner C,
Baud O, Bennoun M, Gomas E, Nicolas G,
Wojtaszewski JF, Kahn A, Carling D, Schuit
FC, Birnbaum MJ, Richter EA, Burcelin R,
Vaulont S (2003) The AMP-activated protein
kinase alpha2 catalytic subunit controls whole-
body insulin sensitivity. J Clin Invest 111
(1):91–98. https://doi.org/10.1172/
JCI16567
- O’Neill HM, Maarbjerg SJ, Crane JD,
Jeppesen J, Jorgensen SB, Schertzer JD,
Shyroka O, Kiens B, van Denderen BJ, Tarno-
polsky MA, Kemp BE, Richter EA, Steinberg
GR (2011) AMP-activated protein kinase
(AMPK) beta1beta2 muscle null mice reveal
an essential role for AMPK in maintaining
mitochondrial content and glucose uptake dur-
ing exercise. Proc Natl Acad Sci U S A 108
(38):16092–16097. https://doi.org/10.
1073/pnas.1105062108
- Viollet B, Athea Y, Mounier R, Guigas B,
Zarrinpashneh E, Horman S, Lantier L,
Hebrard S, Devin-Leclerc J, Beauloye C,
Foretz M, Andreelli F, Ventura-Clapier R, Ber-
trand L (2009) AMPK: lessons from transgenic
and knockout animals. Front Biosci (Landmark
Ed) 14:19–44
- Viollet B, Foretz M (2016) Animal models to
study AMPK. EXS 107:441–469.https://doi.
org/10.1007/978-3-319-43589-3_18
- Foretz M, Hebrard S, Leclerc J,
Zarrinpashneh E, Soty M, Mithieux G,
Sakamoto K, Andreelli F, Viollet B (2010)
Metformin inhibits hepatic gluconeogenesis in
mice independently of the LKB1/AMPK path-
way via a decrease in hepatic energy state. J Clin
Invest 120(7):2355–2369. https://doi.org/
10.1172/JCI40671
- Cao J, Meng S, Chang E, Beckwith-Fickas K,
Xiong L, Cole RN, Radovick S, Wondisford
FE, He L (2014) Low concentrations of met-
formin suppress glucose production in hepato-
cytes through AMP-activated protein kinase
(AMPK). J Biol Chem 289
(30):20435–20446. https://doi.org/10.
1074/jbc.M114.567271
- Fullerton MD, Galic S, Marcinko K, Sikkema S,
Pulinilkunnil T, Chen ZP, O’Neill HM, Ford
RJ, Palanivel R, O’Brien M, Hardie DG,
Macaulay SL, Schertzer JD, Dyck JR, van Den-
deren BJ, Kemp BE, Steinberg GR (2013) Sin-
gle phosphorylation sites in Acc1 and Acc2
regulate lipid homeostasis and the insulin-
sensitizing effects of metformin. Nat Med 19
(12):1649–1654. https://doi.org/10.1038/
nm.3372
- Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T,
Fujii N, Musi N, Hirshman MF, Goodyear LJ,
Moller DE (2001) Role of AMP-activated pro-
tein kinase in mechanism of metformin action.
J Clin Invest 108(8):1167–1174.https://doi.
org/10.1172/JCI13505
- Yu PB, Hong CC, Sachidanandan C, Babitt JL,
Deng DY, Hoyng SA, Lin HY, Bloch KD,
Peterson RT (2008) Dorsomorphin inhibits
BMP signals required for embryogenesis and
iron metabolism. Nat Chem Biol 4(1):33–41.
https://doi.org/10.1038/nchembio.2007.54
- Hao J, Daleo MA, Murphy CK, Yu PB, Ho JN,
Hu J, Peterson RT, Hatzopoulos AK, Hong
CC (2008) Dorsomorphin, a selective small
molecule inhibitor of BMP signaling, promotes
cardiomyogenesis in embryonic stem cells.
PLoS One 3(8):e2904.https://doi.org/10.
1371/journal.pone.0002904
- Yu PB, Deng DY, Lai CS, Hong CC, Cuny
GD, Bouxsein ML, Hong DW, McManus
PM, Katagiri T, Sachidanandan C, Kamiya N,
Fukuda T, Mishina Y, Peterson RT, Bloch KD
(2008) BMP type I receptor inhibition reduces
heterotopic [corrected] ossification. Nat Med
14(12):1363–1369. https://doi.org/10.
1038/nm.1888
- Shen Q, Little SC, Xu M, Haupt J, Ast C,
Katagiri T, Mundlos S, Seemann P, Kaplan FS,
Mullins MC, Shore EM (2009) The fibrodys-
plasia ossificans progressiva R206H ACVR1
mutation activates BMP-independent chon-
drogenesis and zebrafish embryo ventraliza-
tion. J Clin Invest 119(11):3462–3472.
https://doi.org/10.1172/JCI37412
- Kaplan FS, Xu M, Seemann P, Connor JM,
Glaser DL, Carroll L, Delai P, Fastnacht-
Urban E, Forman SJ, Gillessen-Kaesbach G,
Hoover-Fong J, Koster B, Pauli RM,
Reardon W, Zaidi SA, Zasloff M, Morhart R,
Mundlos S, Groppe J, Shore EM (2009) Clas-
sic and atypical fibrodysplasia ossificans pro-
gressiva (FOP) phenotypes are caused by
mutations in the bone morphogenetic protein
(BMP) type I receptor ACVR1. Hum Mutat 30
(3):379–390. https://doi.org/10.1002/
humu.20868
- Shore EM, Xu M, Feldman GJ, Fenstermacher
DA, Cho TJ, Choi IH, Connor JM, Delai P,
Glaser DL, LeMerrer M, Morhart R, Rogers JG,
Smith R, Triffitt JT, Urtizberea JA, Zasloff M,
Brown MA, Kaplan FS (2006) A recurrent
mutation in the BMP type I receptor ACVR1
causes inherited and sporadic fibrodysplasia ossi-
ficans progressiva. Nat Genet 38(5):525–527.
https://doi.org/10.1038/ng1783
- Hao J, Ho JN, Lewis JA, Karim KA, Daniels
RN, Gentry PR, Hopkins CR, Lindsley CW,
Hong CC (2010) In vivo structure-activity
relationship study of dorsomorphin analogues
Compound C: Its Use and Misuse 201
